Latest News and Events
Filter by
Selections
August 30, 2012
Arrowhead Completes Enrollment in Phase 1b Trial of RNAi Drug Candidate CALAA-01
Read MoreAugust 13, 2012
Arrowhead Raises $6.2 Million through Registered Direct Offering of Common Stock and Warrants
Read MoreAugust 9, 2012
Arrowhead Research to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference
Read MoreJuly 11, 2012
Arrowhead Announces Dosing of First Patient with Anti-Obesity Treatment Adipotide® in a Phase 1 Clinical Trial
Read MoreJune 26, 2012